5-Azacytidine
![5-Azacytidine Structure](CAS/GIF/320-67-2.gif)
- CAS No.
- 320-67-2
- Chemical Name:
- 5-Azacytidine
- Synonyms
- AZACITIDINE;AZACYTIDINE;Vidaza;mylosar;5-AC;5 AZC;5-AZCR;5-AZAC;LADAKAMYCIN;5-Azacitidine
- CBNumber:
- CB4383338
- Molecular Formula:
- C8H12N4O5
- Molecular Weight:
- 244.2
- MOL File:
- 320-67-2.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/3/16 17:09:04
Melting point | 226-232 °C (dec.)(lit.) |
---|---|
alpha | 40 º (C=1, H2O 22 ºC) |
Boiling point | 387.12°C (rough estimate) |
Density | 1.4287 (rough estimate) |
refractive index | 1.6590 (estimate) |
storage temp. | -20°C |
solubility | Soluble in DMSO (up to 25 mg/ml), or in Water (up to 12 mg/ml). |
pka | 13.46±0.70(Predicted) |
form | lyophilized powder |
color | White to Off-white |
Water Solubility | 0.5-1.0 g/100 mL at 21 ºC |
Merck | 14,887 |
BRN | 620461 |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 1 month. |
InChIKey | NMUSYJAQQFHJEW-WGDKFINWSA-N |
LogP | -2.191 (est) |
CAS DataBase Reference | 320-67-2(CAS DataBase Reference) |
IARC | 2A (Vol. 50) 1990 |
EPA Substance Registry System | Azacitidine (320-67-2) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() ![]() ![]() GHS07,GHS08,GHS09 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H302-H341-H350-H360FD-H372-H410 | |||||||||
Precautionary statements | P202-P260-P264-P273-P301+P312-P308+P313 | |||||||||
Hazard Codes | T | |||||||||
Risk Statements | 45-46-22 | |||||||||
Safety Statements | 53-22-36/37/39-45 | |||||||||
WGK Germany | 3 | |||||||||
RTECS | XZ3017500 | |||||||||
F | 10-23 | |||||||||
HS Code | 29349990 | |||||||||
Toxicity | LD50 in mice (mg/kg): 115.9 i.p.; 572.3 orally (Palm, Kensler) | |||||||||
NFPA 704 |
|
5-Azacytidine price More Price(15)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | A2385 | 5-Azacytidine ≥98% (HPLC) | 320-67-2 | 100MG | ₹5715.6 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | A2385 | 5-Azacytidine ≥98% (HPLC) | 320-67-2 | 250MG | ₹11875.03 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | PHR1911 | Azacitidine Pharmaceutical Secondary Standard; Certified Reference Material | 320-67-2 | 300MG | ₹39576.2 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | A2385 | 5-Azacytidine ≥98% (HPLC) | 320-67-2 | 1G | ₹40994.28 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | A1287 | 5-Azacytidine Hybri-Max?, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma | 320-67-2 | 1VIAL | ₹2478.93 | 2022-06-14 | Buy |
5-Azacytidine Chemical Properties,Uses,Production
Description
5-Azacytidine is an analog of the nucleoside cytidine which can be incorporated into DNA and RNA. 5-Azacytidine acts as an epigenetic modifier by incorporating into DNA where it irreversibly binds to DNA methyltransferases, thus inhibiting their activity.
Azacitidine is an antineoplastic agent launched for the treatment of myelodysplastic syndrome (MDS). MDS is a group of closely related diseases caused by abnormal blood-forming stem cells of the bone marrow. Azacitidine is indicated for the treatment of all five subtypes of MDS, which consist of refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia.
Chemical Properties
White crystalline solid or powder. Soluble in dimethyl sulfoxide, slightly soluble in ethanol:water (50:50), propylene glycol, polyethylene glycol; slightly soluble in water, saturated octanol aqueous solution, 5% glucose injection, N-methyl-2-pyrrolidone, 0.9% sodium chloride injection and 5% polysorbate 80 aqueous solution; insoluble in acetone, ethanol and methyl ethyl ketone.
Uses
5-Azacytidine, its incorporation into RNA alters RNA synthesis and processing, and results in inhibition of protein synthesis. It has been used as a cancer chemotherapeutic agent. It is a powerful bacteriostatic, antitumor, and mutagenic agent; it also exhibits immunosuppressive, antimitotic, radioprotective, and virostatic effects.
Definition
ChEBI: A N-glycosyl-1,3,5-triazine that is 4-amino-1,3,5-triazin-2(1H)-one substituted by a beta-D-ribofuranosyl residue via a N-glycosidic linkage.
Biological Functions
Azacitidine is given subcutaneously for the treatment of myelodysplastic syndrome, and serum levels generally are maximized within 30 minutes. The parent drug and its metabolites are excreted in the urine. Azacitidine is carcinogenic and teratogenic in rodents, and leukopenia, thrombocytopenia, and neutropenia are the most common reasons for drug discontinuation or dosage reduction.
General Description
White crystalline powder.
Air & Water Reactions
Slightly water soluble. Unstable in solution.
Reactivity Profile
5-Azacytidine is sensitive to light (may discolor). 5-Azacytidine is sensitive to oxidation. 5-Azacytidine is unstable in solution. 5-Azacytidine undergoes hydrolysis in aqueous buffers. 5-Azacytidine is incompatible with strong oxidizers.
Fire Hazard
Flash point data for 5-Azacytidine are not available; however, 5-Azacytidine is probably combustible.
Biological Activity
DNA methyltransferase inhibitor. Incorporates into DNA forming covalent adducts with cellular DNMT1, depleting enzyme activity. Induces demethylation and reactivation of silenced genes. Improves the efficiency of reprogramming of stem cells.
Safety Profile
Confirmed carcinogen with experimental carcinogenic, neoplastigenic, tumorigenic data. Poison by ingestion, intravenous, and intraperitoneal routes. Human systemic effects by intravenous route: nausea, vomiting and dlarrhea, reduction in white cell count (luekopenia and agranulocytosis). An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. A skin irritant. When heated to decomposition it emits toxic fumes of NOx.
Carcinogenicity
Azacitidine is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.
Shipping
UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials.
Incompatibilities
Azacitidine is Incompatible with oxidizers (chlorates, nitrates, peroxides, permanganates, perchlorates, chlorine, bromine, fluorine, etc.); contact may cause fires or explosions. Keep away from alkaline materials, strong bases, strong acids, oxoacids, epoxides. Contact with alkali metals, nitrides, and strong reducing agents such as hydrides may form flammable and/or toxic gases. May react with anhydrides forming acids and esters, generating noticeable heat, and also with oxoacids and carboxylic acids to form esters plus water, but the heat of reaction in the latter case typically is low. Keep away from isocyanates and epoxides; may initiate their polymerization. Azacitidine is sensitive to light and oxidation and unstable in solution. It undergoes hydrolysis in aqueous buffers.
Waste Disposal
It is inappropriate and possibly dangerous to the environment to dispose of expired or waste drugs and pharmaceuticals by flushing them down the toilet or discarding them to the trash. Household quantities of expired or waste pharmaceuticals may be mixed with wet cat litter or coffee grounds, double-bagged in plastic, discard in trash. Larger quantities shall carefully take into consideration applicable DEA, EPA, and FDA regulations. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.
5-Azacytidine Preparation Products And Raw materials
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Dr. Reddy's Laboratories Ltd | +91-4049002900 +91-4049002900 | Hyderabad, India | 165 | 58 | Inquiry |
Anant Pharmaceuticals Pvt Ltd | +91-8550986868 +91-9485998001 | Haryana, India | 461 | 58 | Inquiry |
J S LABS | +91-7330612784 +91-7330612784 | Tamil Nadu, India | 160 | 58 | Inquiry |
HRV Global Life Sciences | +91-9820219686 +91-9820219686 | Telangana, India | 379 | 58 | Inquiry |
Shilpa Medicare Limited (SML) | +91-8532238704 +91-9320649838 | Karnataka, India | 61 | 58 | Inquiry |
Svak Life Sciences | +91-9963463333 +91-9705383777 | Hyderabad, India | 101 | 58 | Inquiry |
Basil Drugs AND Pharmaceuticals Pvt Ltd | +91-2249700250 +91-9619320820 | Mumbai, India | 108 | 58 | Inquiry |
Gland Chemicals Pvt Ltd | +91-9492733833 +91-9346729196 | Telangana, India | 16 | 58 | Inquiry |
Laurus Labs Ltd | +91-4066594333 +91-4039804333 | Telangana, India | 50 | 58 | Inquiry |
Sakar Healthcare | +91-8976292690 +91-9967572302 | Gujarat, India | 47 | 58 | Inquiry |
Supplier | Advantage |
---|---|
Dr. Reddy's Laboratories Ltd | 58 |
Anant Pharmaceuticals Pvt Ltd | 58 |
J S LABS | 58 |
HRV Global Life Sciences | 58 |
Shilpa Medicare Limited (SML) | 58 |
Svak Life Sciences | 58 |
Basil Drugs AND Pharmaceuticals Pvt Ltd | 58 |
Gland Chemicals Pvt Ltd | 58 |
Laurus Labs Ltd | 58 |
Sakar Healthcare | 58 |
Related articles
- 5-Azacytidine: Mechanism of Action AND Mechanism of Resistance
- 5-Azacytidine (NSC-102816), 4-amino-1-β-d-ribofuranosyl-1,3,5-triazine- 2(1H)-one, 5-azacitidine, C8H12N4O5, Mr 244.21, is a p....
- Mar 16,2024